D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Zebra Technologies
ZBRA
$13.5B
| $5.9M | 0.01% |
28,173
-38,541
| -58% | -$7.25M |
|
1402
Adtran
ADTN
$675M
| $5.89M | 0.01% |
429,932
+246,290
| +134% | +$3.4M |
|
1403
3M
MMM
$91.8B
| $5.88M | 0.01% |
33,864
+25,784
| +319% | +$4.34M |
|
|
GWPH
1404
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $5.88M | 0.01% |
34,900
-10,100
| -22% | -$1.5M |
|
|
XEC
1405
PUT
DELISTED
CIMAREX ENERGY CO
XEC
| $5.87M | 0.01% |
84,000
+25,600
| +44% | +$1.84M |
|
1406
Advanced Energy
AEIS
$10.1B
| $5.86M | 0.01% |
118,047
-75,832
| -39% | -$3.69M |
|
1407
Vishay Intertechnology
VSH
$4.6B
| $5.86M | 0.01% |
317,387
-61,339
| -16% | -$1.23M |
|
|
AY
1408
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $5.85M | 0.01% |
300,599
+89,354
| +42% | +$1.7M |
|
1409
CALL
Honeywell
HON
$76.4B
| $5.85M | 0.01% |
39,045
+31,194
| +397% | +$4.36M |
|
1410
Coherent
COHR
$43.4B
| $5.81M | 0.01% |
156,130
-13,802
| -8% | -$510K |
|
1411
HighPeak Energy
HPK
$838M
| $5.8M | 0.01% |
575,000
| – | – |
|
1412
Colliers International
CIGI
$5.17B
| $5.79M | 0.01% |
86,600
+17,400
| +25% | +$1.11M |
|
1413
MBIA
MBI
$275M
| $5.79M | 0.01% |
607,789
+161,113
| +36% | +$1.58M |
|
1414
PUT
Alaska Air
ALK
$5.11B
| $5.78M | 0.01% |
103,000
-45,700
| -31% | -$2.79M |
|
1415
Texas Instruments
TXN
$248B
| $5.77M | 0.01% |
54,419
+29,482
| +118% | +$3.05M |
|
1416
Silicon Laboratories
SLAB
$7.14B
| $5.77M | 0.01% |
71,366
-62,657
| -47% | -$5.21M |
|
|
MBT
1417
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $5.77M | 0.01% |
763,343
-24,958
| -3% | -$198K |
|
1418
Dollar General
DG
$28.4B
| $5.76M | 0.01% |
48,260
+34,560
| +252% | +$4.02M |
|
1419
CALL
Biogen
BIIB
$30.9B
| $5.74M | 0.01% |
24,300
-150,100
| -86% | -$47.3M |
|
1420
Flowserve
FLS
$8.94B
| $5.74M | 0.01% |
127,166
-21,597
| -15% | -$943K |
|
|
GG
1421
PUT
DELISTED
Goldcorp Inc
GG
| $5.71M | 0.01% |
498,800
-291,900
| -37% | -$3.14M |
|
1422
Zillow
Z
$7.78B
| $5.69M | 0.01% |
163,882
+81,726
| +99% | +$2.92M |
|
1423
Toyota
TM
$228B
| $5.69M | 0.01% |
48,215
+15,992
| +50% | +$1.93M |
|
|
SHYF
1424
DELISTED
The Shyft Group
SHYF
| $5.68M | 0.01% |
643,036
+194,191
| +43% | +$1.66M |
|
1425
ORIX
IX
$42.7B
| $5.68M | 0.01% |
394,855
+338,485
| +600% | +$4.99M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.